PipelineReview.com - All Products

Show Cart

All Products

Results 101 - 120 of 188

Feb 2016 Competitor Analysis: Flavivirus Vaccines: Zika, Dengue, Chikungunya, West Nile, Yellow Fever, Japanese Encephalitis & Tick-Borne Encephalitis Virus Vaccines

Feb 2016 Competitor Analysis: PTH Receptor Agonists 2016 and Teriparatide Biosimilars and Biosuperiors

Feb 2016 RORgamma Modulators 2016: A comparative analysis of the landscape of RORgamma antagonists and agonists

Jan 2016 Competitor Analysis: Inhibitors of the bromodomain and extra-terminal domain (BET) family

Nov 2015 Antibody-Drug Conjugates 2016: Perspectives & Opportunities - a Pipeline, Technology, Stakeholder & Business Analysis

Sep 2015 Competitor Analysis: Amyloid beta- and Tau-Targeted Antibodies & Vaccines

Sep 2015 Competitor Analysis: Interleukin-4/-13 (IL-4/-13) Inhibitors or Receptor Antagonists

Sep 2015 Competitor Analysis: Sphingosine-1-Phosphate (S1P) Receptor Modulators

Sep 2015 Competitor Analysis: Interleukin-23 & IL-12/23 Antagonists

Aug 2015 Competitor Analysis: Interleukin-17/Receptor (IL-17/R) Antagonists

Jul 2015 Filgrastim & Pegfilgrastim Biosimilars & Biosuperiors 2015 – a G-CSF & GM-CSF Competitor Analysis

Mar 2015 2014 Sales of Recombinant Therapeutic Antibodies & Proteins

Mar 2015 Engineered TCR and CAR Immunotherapeutics 2015

(Discount: 20.00%)

Feb 2015 Competitor Analysis: Specific and Bispecific Her3 Antibodies

Jan 2015 Competitor Analysis: Alpha Synuclein and LRRK2 Inhibitors - Novel Drug Candidates for Parkinson’s Disease

Jan 2015 Competitor Analysis: Nonalcoholic Steatohepatitis (NASH) – Novel Drug Candidates

Dec 2014 Recombinant Coagulation Factors 2015: Maturation of recombinant clotting factor pipeline and emergence of gene therapy and alternative procoagulants

(Discount: 10.00%)

Nov 2014 Competitor Analysis: Cancer Peptides

Nov 2014 Competitor Analysis: Cardiometabolic Peptides

Oct 2014 Competitor Analysis: Ebola Virus Vaccines and Therapeutics

Shopping cart

Cart empty

Latest report

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Featured Products

Report Package: “Drug the Undruggable” Technologies

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Latest Target Pipeline

STING Agonists & Antagonists

Shopping cart

Cart empty

Latest report

Targeted Protein Degradation by Novel PROTACs and Molecular Glues 2020: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

Featured Products

Report Package: “Drug the Undruggable” Technologies

RNA-Targeted Small Molecules 2019: a landscape analysis of companies, technologies, targets, investors and partners from an industry perspective

T-Cell & NK-Cell Engaging Bispecific Antibodies 2019: a business, stakeholder, technology and pipeline analysis

Latest Target Pipeline

STING Agonists & Antagonists

La Merie Biologics

FREE Weekly News Bulletin

2019 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing